Sofinnova Management X, L.P.'s Form 4 filing
CinCor Pharma, Inc. (CINC) · filed Aug 15, 2022
- Accession no.
- 0001104659-22-091184
- Filed
- Aug 15, 2022, 3:46 PM ET
- Trade date
- Aug 11, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $15.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sofinnova Management X, L.P.CIK 0001680194 | 10% Owner |
| Sofinnova Venture Partners X, L.P.CIK 0001680200 | 10% Owner |
| Katabi MahaCIK 0001720685 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2022 | Common Stock | PPurchaseAcquired | +500,000 | $30.00 | +$15,000,000 | 6,073,949 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.